US$ 21.75
bpc-157 human clinical trials safety regulatory status fda warning Legal Status: Regulations and Compounding KevinMD.com - Patients are refusing
Description
Cell Biol 170, 349355 (2005)
They're a good option for daily use but may not provide the immediate relief that IV infusion offers

Nature Reviews Endocrinology, 9(6), 366376
In this regard, Restylane is likely the better brand when it comes to under-eye fillers